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ABSTRACT 
Objective: The aim of the study was to develop and characterize mucoadhesive microbeads for oral sustained release of atorvastatin by using 
hydrophilic polymers and application of different process variables in designing of pH sensitive swellable microbeads. 
Methods: Microbeads were prepared by ionic gelation method. The compatibility studies of atorvastatin with polymers were investigated by 
differential scanning calorimeter and fourier transform infrared spectroscopy studies. In this work process variable like optimization of curing 
agents and their quantity, effect of rpm, and their influence in drug entrapment were studied. Prepared beads were characterized for particle size, 
swelling index, erosion studies and drug release studies. 
Results: Mixture of alginate and carbopol 934 P at 3.3 % w/v shows sustained release and good mucoadhesive capacity. Furthermore, drug loading 
and swelling increased with the use of a combination of polymers. On basis of in vitro release studies and swelling studies, it was observed that 
sodium alginate coated with carbopol 934 P showed sustained release of 84.5 % at end of 10 h in 6.8 phosphate buffer. The optimised batch 
followed peppas and higuchi release mechanism and releasing the drug by non-fickian transport. 
Conclusion: The alginate beads with a combination of carbopol 934P showed a sustain release pattern. The release rate and swelling of atorvastatin 
beads could be adjusted by adding other hydrophilic polymers or by optimising curing agents, curing time and their volume. The zero order of drug 
release was confirmed for all the batches. The in vitro data was better fit to Higuchi’s diffusion model and diffusion rate limited. 
Keywords: Atorvastatin, Mucoadhesive microbeads, Needle effect and Sustained release  




Among the multiple routes of drug delivery [1], oral route is the 
most suitable, used and most accepted one by the patients for the 
delivery of the therapeutically active drugs over the past few years, 
many controlled releases, Controlled release drug delivery systems 
have been developed using a variety of innovative techniques with 
wide variety of polymeric matrices.  
By adopting controlled drug delivery many of the obstacles, for 
example, they maximize drug absorption, reduce peak plasma 
fluctuations and minimize potential side effects etc [2, 3] will be 
overcome and getting much patient compliance [4] and improve the 
rate of bioavailability. Ionic gelation technique involves ionic cross-
linking between polyelectrolyte biopolymers such as alginates, 
chitosan, etc. and counterions to produce a cross-linked matrix 
which would provide the desired controlled release rate of the drug 
molecule. From a polymer chemistry viewpoint, the development of 
interpenetrating network polymers (IPNs) of sod. Alginate is 
attractive because, by definition, the IPNs contain two polymers, 
each in a network form, which can be cross-linked in the presence of 
each other to give a three-dimensional network structure producing 
free volume for the easy encapsulation of drugs easily. Bio/ 
mucoadhesive [5] microspheres have few advantages such as 
marked efficient absorption and improved the rate of bioavailability 
of drugs owing to high surface to volume ratio, a much more close 
contact with the mucus layer following oral consumption and 
specific targeting of drugs to the desired absorption site.  
Atorvastatin is a new class of lipid-lowering compound that selectively 
inhibit the intestinal absorption of cholesterol and decrease 
cholesterol absorption. After oral administration alone, atorvastatin is 
rapidly absorbed, reach maximum plasma concentrations within 1-2 h. 
Atorvastatin belongs to biopharmaceutics classification system class II 
category, showing low oral bioavailability (12%) [6], due to low 
aqueous solubility (0.15 mg/ml), high presystemic clearance in the 
gastrointestinal mucosa (80%), and extensive hepatic first-pass effect, 
thus their bioavailability depends on dissolution features. Its having 
half-life is 11-19 h in humans [7-9]. It is insoluble in aqueous solutions 
at pH 4 and below. It is insoluble in an aqueous solution of pH 4 and 
below, it is very slightly soluble in water and 7.4 pH phosphate buffer. 
The intestinal permeability of atorvastatin is high at the 
physiologically relevant intestinal pH [10]. However, it is reported that 
the absolute bioavailability of atorvastatin is 12% after a 40 mg oral 
dose [11]. In view of its long biological half-life and less bioavailability 
of atorvastatin and the associated side effects, we have chosen 
atorvastatin for developing the controlled release beads with sodium 
alginate as a coating polymer. 
Polymers belong to the class of polysaccharides are widely used in oral 
drug delivery systems because of their simplicity to obtain the desired 
drug delivery system and drug release profile. In our recent paper, we 
have shown the ability of hydroxypropyl methyl cellulose K15M, 
carbopol 934P and polyvinyl pyrrolidine (PVP) polymers to form a 
high-viscosity hydrogels using a very small amount of hydrophilic 
materials. In our present study, we extend the investigation by using 
polymers in combination with Na. alginate to form hydrogel complex 
beads and to check the sustainability of the therapeutic effect of drug 
obtained from the matrix. Among existence of various natural 
polymers, alginates have been used as matrices to achieve controlled 
release drug delivery due to their hydrogel-forming properties. The 
sodium alginate [12] has been used as a controlled release matrix 
material in medicine and it can absorb water 200-300 times to their 
own weight. It consists of linear polymer of ß-(1-4) mannuronic acid 
(M) and (1-4) guluronic acid (G) residues in varying proportions and 
arrangements.
Accordingly, the objective of the current study was to optimise the 
composition of alginate beads with hydrophilic polymers to produce 
 It has been shown that the G and M units are joined 
together anonymous. These residues are arranged in homopolymeric 
and heteropolymeric blocks. 
International Journal of Applied Pharmaceutics 
ISSN- 0975-7058                               Vol 9, Issue 3, 2017 
Reddy et al. 
Int J App Pharm, Vol 9, Issue 3, 2017, 20-30 
21 
stable beads with optimum specifications. The major objective of the 
current experiment is made with different objectives i.e. the effect of 
conc. of sodium alginate, the effect of tri and divalent curing agents, 
the effect of rpm, effect of curing volume and effect of curing time. 
In the present study, we have aimed to formulate the stable alginate 
beads by ionic gelation technique with hydrophilic polymers naming 
carbopol 934P, polyvinyl pyrrolidone (PVP) and hydroxypropyl 
methyl cellulose K15 (HPMC K15). These polymers undergoes ionic 
interactions with di and trivalent compounds, for this reason, we 
have used both metal ions as cacl+2 and alcl+3
MATERIALS AND METHODS 
 as curing agents for 
the cross linking of alginate material and formed beads were 
evaluated the characterization of beads. 
Atorvastatin pure drug sample obtained from Aizant, Hyderabad, 
India, sodium alginate 45 cps (1% w/v solution in water at 25 ° C), 
carbopol 934P (SD fine chemicals. Mumbai), hydroxypropyl methyl 
cellulose K15 M, polyvinyl pyrrolidone, aluminium chloride 
dihydrate, calcium chloride, potassium dihydrogen phosphate, 
potassium hydroxide pellets (E. Merck, India), ethanol and sodium 
lauryl sulphate (SLS) were used. All other used reagents were of 
analytical grade. 
Equipment 
Weighing balance, sonicator (Remi model, Mumbai), homogenizer, 
(Remi, India),USP tablet disintegrating test apparatus,dissolution 
test apparatus USP, model TDT-08L,electro lab, uv-visible 
spectrophotometer, scanning electron microscope (SEM; S-4100, 
Hitachi, Japan), X-Ray diffractometer, Bruker spectrophotometer 
(Model-220, Germany) and syringe needles 22 G, 24 G etc. 
Preparation of cross-linked swellable alginate hydrogel beads 
Cross-linked alginate beads were prepared by adopting orifice 
gelation technique which is simple, easiest and simple method of 
entire microencapsulation techniques. For micro beads formation, 
100 ml of 3% w/v aqueous solution of sodium alginate which 
contains atorvastatin 100 mg and 0.30 % w/v of different 
mucoadhesive hydrophilic polymers (which already dispersed in 
water and kept aside one night to develop interpenetrated network) 
naming carbopol 934P, polyvinyl pyrrolidine and hydroxypropyl 
methyl cellulose K15M. After uniform dispersion of above mucilage, 
it was discharged dropwise from syringe needle size-22 needle into 
100 ml of an aqueous 5% w/v aluminium chloride/calcium chloride 
solution being stirred at different rpm. Keep distance between 
needle to curing medium at least 15 cms. gap to get stable spherical 
beads. Since sodium alginate gel can easily be formed by this ionic 
interaction in an aqueous medium, gel beads are commonly obtained by 
dropping solutions of sod. alginate into a solution which contains 
different divalent and trivalent electrolytes. Formed soft beads cured for 
a period of 30 to 60 min. into curing solution to harden the surface of soft 
beads. The concentration of Alcl+3
 
 in the solution ranged from 5 % w/v. 
The stirring was continued for one hour and make sure that free air 
bubble should be made throughout polymer solution by subjecting to 
sonicator for more than 1 h and formed the aluminium alginate beads 
were separated by filtration and decantation, obtained beads washed 
with distilled water three times continuously to remove traces of curing 
medium, and make air dried overnight. 
Table 1: Formulation of atorvastatin microbeads 
Batch code Sodium alginate (% w/v) Atorvastatin (mg) Curing agent Curing agent (%) Curing time (h) RPM 
A 2 100 Cacl2 2.5 0.25 100 
B 3 100 Cacl2 2.5 0.25 100 
C 4 100 Cacl2 2.5 0.25 100 
D 2 100 Alcl3 5 0.5 200 
E 3 100 Alcl3 5 0.5 200 
F 4 100 Alcl3 5 0.5 200 
G 3 100 Alcl3 5 1 200 
H 3 100 Alcl3 5 1 300 
 
Table 2: Formulation of optimised alginate beads with different hydrophilic polymers 
Code Polymers (3%+0.3%w/v) Drug (mg) Curing agent Curing agent 
(%) 
RPM Curing time (h) Curing volume 
(ml) 
A1 Sod. Alginate+carbopol 934P 100 Alcl 5 +3 200 1 100 
B1 Sod. Alginate+carbopol 934P 100 Alcl 5 +3 200 1 150 
C1 Sod. Alginate+carbopol 934P 100 Alcl 5 +3 200 1 200 
D1 Sod. Alginate+HPMC K15 100 Alcl 5 +3 200 1 100 
E1 Sod. Alginate+poly vinyl pyrrolidine 100 Alcl 5 +3 200 1 100 
 
Table 3: List of various optimised parameters 
S. No. Conc. of sodium alginate 
(%) 
rpm  Curing medium 
(ml) 
Curing time  
(min.) 




1 3 200 100 60 Aluminium 
chloride 
5 22 G 
 
Experimental design 
Determination of absorption maxima 
10 µg/ml solutions were taken to determine absorption maxima. 
Initially blank buffer solution was kept and scanned in the region of 
200-400 nm by using UV-visible spectrophotometer. Then drug 
sample was kept for analysis and scanned in the above region.  
Drug entrapment efficiency  
The prepared drug-loaded microspheres were checked for their 
drug content. Accurately weighed 100 mg of the dried 
microspheres were powdered and dissolved in 100 ml 
phosphate buffer (pH 6.8). The solution was kept overnight and 
then filtered using 0.45 µm cellulose acetate syringe filter, after 
series of suitable dilutions with phosphate buffer were done, 
solutions were filtered and analyzed spectrophotometrically at 
243 nm by using uv-visible spectrophotometer (UV-800 
Shimadzu, Japan). The entrapment efficiency was determined 
using the following equation:  
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Determination of swelling properties 
The dynamic swelling property of microbeads was determined by 
placing beads in the both i.e. acidic and 6.8 pH phosphate buffer 
medium under standard conditions. Prepared microbeads of known 
weight were placed in dissolution solution for specified time and 
were maintained 37+0.5 ° c temperature with 70 rpm. The swollen 
microcapsules were collected by decantation at different intervals of 
time. The wet weight of the swollen alginate cross-linked 
microcapsules was determined by first blotting the particles with 
filter paper to remove absorbed water on the surface and then 
weighing immediately again on an electronic balance. The difference 
in given values give the percentage of swelling of microcapsules in 
the dissolution media and it was calculated by using equation. 
 
Where Sw = percentage of swelling of microcapsules/beads, Wt = 
weight of the microcapsules at time t, and WO = initial weight of the 
microcapsules. 
Erosion studies 
The dried alginate beads were weighed and placed in a dissolution 
basket, which contains phosphate buffer (pH 6.8) at 70 rpm. After 
every 1h intervals of time, the swelled beads were removed from the 
basket carefully and dried at room temperature. The beads were 
dried after water was been removed, and the dried beads were 
reweighed. The beads were then placed back in the basket. This 
entire process lasted 11 h. Erosion study was performed using the 
following formula. 
 
Where Wo = Initial beads weight and W1 = weight of beads after drying. 
Mucoadhesive testing by in vitro wash-off test 
The functionality mucoadhesive property of the alginate base 
microbeads was evaluated by in vitro wash off test. Collect freshly 
excised pieces of the intestinal mucosa (3 × 3 cm2
Differential scanning calorimetry  
) from sheep were 
mounted onto glass slides (3 × 2 inches) with cyanoacrylate glue. 
Approximately 50 micro beads were placed and spread onto each 
wet rinsed tissue specimen, and immediately the slide was hung 
onto the arm of a USP tablet disintegrating test apparatus. The tissue 
specimen was given a slow, regular up-and-down movement in the 
disintegration fluid at 37 ° C contained in a one-liter basket vessel 
and maintain baskets move up and down continuously at 70 rpm. 
After the definite time intervals, the machine was stopped and the 
number of microcapsules still adhering to the tissue was counted. 
(Gastric pH) 0.1N Hcl, pH 1.2 and (intestinal pH) phosphate buffer of 
pH 6.8 were used as test fluids. The difference in adherence of 
swelled alginate beads to glass slides before and after were given 
knowledge of the mucoadhesive strength of microbeads. 
Scanning electron microscopy  
The surface morphology of microbeads was investigated by using 
scanning electron microscope (USA model). A known amount of sample 
were placed on a brass stub using double-sided adhesive tape and made 
electrically conductive by coating with a thin layer of gold and SEM 
images were observed at different accelerating voltage [14-15].  
DSC studies were carried out on the thermal analyzer (TA-60WS), 
shimadzu. A few milligrams of the sample, were hermetically sealed 
into aluminium pans and heated under a nitrogen atmosphere with 
the heating rate of 10 ° C/min. [16-18]  
X-ray diffraction study 
Change in crystalline structure of the drug when loaded into alginate 
beads was measured by using X-Ray diffract meter [19]. 
In vitro release studies 
in vitro release of prepared microbeads were assessed in triplicate by 
using united states pharmacopoeia (USP) dissolution type II apparatus 
(Basket Type) at 37±0.5 ° C under 70 rpm. A freshly prepared 
phosphate buffer of pH 6.8 (900 ml) was used as dissolution medium 
throughout the process. Microbeads containing 20 mg equivalent of 
the drug was placed in 900 ml of dissolution medium (phosphate 
buffer pH 6.8 with methanol in 9:1ratio). The revolution speed of the 
basket was maintained at 70 rpm. At different time intervals, 5 ml of 
dissolution medium was collected and the dissolution media was 
always replenished with a fresh stock solution of 6.8 buffer solution. 
Suitable dilutions were done with the dissolution fluid; the samples 
were analyzed for the drug concentration by using UV-Visible 
spectrophotometer (Shimadzu, Japan) at 243 nm. [20]. 
Release kinetics 
To study the release kinetics, data obtained from in vitro dissolution 
study was fitted in various kinetic models: zero order as cumulative 
percent of drug released vs. time, first order as log cumulative 
percentage of drug remaining vs. time and Higuchi's model as 
cumulative percent drug released vs. square root of time, Hixon crowel 
describes the release from systems when there is a change in a surface 
area and diameter of particles. To determine the mechanism of drug 
release [21], the data was fitted into Korsmeyer and Peppas equation 
as log cumulative percentage of drug released vs. log time and the 
exponent n was calculated from the slope of the straight line. For slab 
matrix, if the exponent is 0.5, then diffusion mechanism is fickian; if 
0.5<n<1.0, then it an indication of anomalous transport. If n is 1.0, it is 
case II transport and if n>1.0, then it is confirmed as super case II 
transport or non-fickian diffusion. 
RESULTS AND DISCUSSION 
UV spectra (λ max) of atorvastatin calcium 
10 µg/ml solutions of atorvastatin were taken to determine 
absorption maxima. Atorvastatin sample was observed scanned in 
the range of 200-400 nm. Absorption maxima were found to be 243 
nm. Hence all further analysis was carried out at 243. 
Atorvastatin solubility in various buffers  
Pure drug atorvastatin undergoing solubility less than 25.04 μ±0.46 
µgm/ml. Atorvastatin has the highest solubility in pH 6.8 phosphate 
buffer with 1.5% (w/v) sodium lauryl sulphate (217.1 μg/ml). The 
addition of SLS increased the solubility of atorvastatin in pH 6.8 
phosphate buffer. The solubility of atorvastatin was highest in pH 6.8 
buffer compared with other buffers; hence, further dissolution testing of 
atorvastatin microspheres was performed by using pH 6.8 phosphate 
buffer with the addition of sodium lauryl sulphate in desired 
concentrations of 0.5%, 1%, and 1.5% (w/v). The solubility values of 
atorvastatin in different buffer medium were predicted in above table 4. 
 
Table 4: List of solubility values in different buffers 
S. No. Medium Solubility mg/ml 
1 6.0 Phosphate buffer 20.12±1.12 
2 6.8 Phosphate buffer 70.12±2.34 
3 7.4 Phosphate buffer 68.89±0.32 
4 0.5 % SLS in 6.8 Phosphate buffer 72.5±2.64 
5 1 % SLS in in 6.8 Phosphate buffer 115.12±7.36 
6 1.5 % SLS in in 6.8 Phosphate buffer 217.±0.89 
7 0.5 % SLS in Phosphate buffer 7.4 90.34±0.56 
8 1 % SLS in Phosphate buffer 7.4 97.12±6.45 
9 1.5 % SLS in Phosphate buffer 7.4 126,23±2.24 
 *n = 3 (average±SD) 
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Fig. 1: UV spectra of atorvastatin calcium in 6.8 phosphate buffer 
 
FTIR studies [22, 23]  
FT-IR spectra were recorded on a bruker spectrophotometer by 
using KBr discs in the range of 4000-450 cm-1. FT-IR analysis was 
performed using a sample of atorvastatin with various excipients at 
1:1 mass/mass ratio. In the FTIR spectrum of sodium alginate 
powder, the various distinct peaks of alginate evident are those of 
the carbonyl at 1609 cm-1, hydroxyl group at 3429 cm-1, and 
carboxyl and carboxylate groups between 1000 and1400 cm-1. The 
absorption band around 2880, 1656, 1421 and 1080 cm-1 
corresponds to the stretching of–CH, COO-, C-O-C,-CH and-CH, 
respectively.  
FTIR spectra of atorvastatin showed presence of their 
characteristics band at 3362 cm-1for (-OH), 3236 cm-1 for (-NH), 
2971 cm-1 for (-CH3), 2824 cm-1 for (-CH aromatic), 1649 cm-1 for 
(C=O), 1578 cm-1 for (C-N), and 1432 cm-1 for (C-C) functional 
groups. The cross-linking process with aluminium ion caused an 
obvious. The shift to higher wave number and a decrease in intensity 
of COO-stretching peaks, and a decrease in intensity of 1031 cm-1
Alginate derivatives are having mucoadhesive properties. In this 
study sodium alginate used as a coating material and that will be 
used in combination of different hydrophilic polymers in little 
concentrations were used. From the observed data, it was observed 
that increase in the molecular weight of the mucoadhesive polymers 
increases the drug entrapment efficacy. This can be due to increase 
in the viscosity of the polymeric solution which, the greater 
availability of aluminium binding sites in the network of polymeric 
chains. As a result formation of the more intact, denser matrix 
network, entrapping a higher amount of drug.  
 
peak of alginate. The results clearly revealed the compatibility of the 
drug with the excipients used in the formulation. 
Effect of concentration of sodium alginate 
Overall results show that combination of alginate with other 
hydrophilic polymers, the release becomes more sustained. The 
decrease in conc. of sodium alginate, it gives less compact beads and 
provides lesser no. of binding sites along alginate chains for 
Ca+2/Al+3
The higher the amount of sodium alginate in the beads, the lower the 
swelling rate that more sustained release was observed with the 
combination. From the studies, it was confirmed that stable beads 
were formed in sodium alginate at 3% w/v only then 2% w/v. The 
beads prepared with 2 % w/v were not observed much stable after 
drying time and they become changes in their appearance. At 4% 
w/v. sodium alginate solution is making difficulty in passing through 
syringe needle grade no. 22 at the time of discharge into curing 
medium because of their higher viscosity. So it is confirmed that out 
of all concentrations best one found to be 3% w/v. and same used in 
further studies. 
 ions resulting in a compact gel with less viscosity, which in 
turn increases the influx of divalent ions leading to decrease in 
encapsulation efficiency. 
3% sodium alginate>2 % sodium alginate 
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Fig. 2: FTIR spectras of a) pure sodium alginate, b) pure carbopol 934P, c) pure atorvastatin, d) mixture of HPMC K 15 and atorvastatin 
and e) physical mixture 
 
Effect of stirring 
The rate of stirring has much influence in the formation of stable 
beads. After getting discharging of sodium alginate solutions into 
curing medium, beads were formed because of gelation reaction 
between alginate and curing agents. At slow rpm, the beads not 
developed properly in its strength and at higher rpm surface of beads 
were disrupted because of generation of high shear force. The stirring 
rate during crosslinking is believed to be a determining typical factor 
that affects the bead size and the yield. With very high stirring rate i.e. 
at 300 rpm being responsible for the reduction in the yield. 
Accordingly, the stirring rate was kept at 200 rpm and was maintained 
with all formulation. This ensures that any variation in the bead size or 
morphology will be due to the variation in the composition. 
 
 
Fig. 3: Dissolution profile of optimized batch with different rpms. Results are given in mean of triplicate 
Reddy et al. 
Int J App Pharm, Vol 9, Issue 3, 2017, 20-30 
25 
Effect of curing time 
The curing time has a major role in developing rigid layer during gelation 
reaction. Upon extending curing beyond 30 min to 60 min beads 
becomes many compacts in comparison to 10 min and 20 min. It was 
also confirmed that at 60 min the diffuses into curing medium and 
becomes less in drug encapsulating efficiency and makes delay in drug 
release. So curing time 1 h was selected for remaining studies. 
The extent and rate of cross-linking depend on the valency of a 
cross-linking agent, molecular size of the drug and concentration of 
the agent as well as on the speed and curing time during processing. 
The water soluble and low molecular mass drugs have poor 
entrapment compared to insoluble and large molecular mass drugs. 
The percentage entrapment efficiency decreased with an increase in the 
time of exposure to the cross linking agent may be due to the increased 
release of the drug from the matrix at the longer time of exposure. Since 
prolonged exposure in the curing medium caused greater loss of drug 
through cross-linked alginate microsphere. Accordingly, the cross linking 
time was kept constant (1 h) in all formulations. 
Effect of curing volume 
It was studied the effect of the volume of curing reagent on drug 
entrapment efficiency and drug release rate the microbeads were 
formulated by taking different volumes (50,100 and 150 ml) of the 
curing agent's solution. The entrapment efficiency was found to be 
increased with increase in the volume of curing agent up to 150 ml and 
then entrapment efficiency has decreased the reason was contributed to 
chances of leaching of the drug in bulk volumes of the curing solution. 
The atorvastatin micro beads formulated by taking 100 ml volume as 
curing reagent were showed good entrapment efficiency and desired 
drug release rate. Hence, 100 ml of curing reagent was selected for 
further studies. Dissolution profiles of the optimised batch with different 





Fig. 4: Dissolution profiles of the optimized batch with different 
curing medium 100 ml and 200 ml (left side) and with different 
curing agents (right side). Results are given in mean of 
triplicate 
 
Effect of curing agent 
In present studies alginate beads prepared with different curing 
agents naming calcium chloride and aluminium chloride. The 
divalent compound cacl+2 form two-dimensional network when 
compared to aluminium chloride as it forms a three-dimensional 
network. Curing agent aluminium chloride has gained three-
dimensional networks in its orientation because of greater valence 
i.e. three in comparison to two of calc2
The incorporation efficiencies were generally higher for the 
beads cross-linked with Al
, and compact beads were 
formed with aluminium chloride at 5% w/v and make delay in drug 
release observed relatively. At lower concentrations of calcium 
chloride/aluminium chloride, the beads showed larger pores due to 
insufficient cross-linking which has resulting in lower drug 
entrapment, so for further studies was implemented in all 
formulations as it gives close compact network in the orientation of 
drug molecules in the polymer. 
Although the aluminium has a small size as compared to calcium, the 
release of drug from the hydrogel beads cross-linked with 
aluminium chloride was found to be more sustained as compared to 
the beads crosslinked with calcium chloride. The reason is that 
aluminium carries an extra charge than calcium chloride. This three-
dimensional bonding results in extended cross-linking sites 
throughout whole beads. Hence, it releases the drug at a slow 
manner as compared to divalent compound calcium chloride. 
Dissolution profiles of the optimized batch with different curing 
agents were showed in fig. 4. 
Role of needle and its position 
Information of stable spherical shape beads selection of needle 
size and its orientation plays a vital role. In the case of alginate 
which contains carbopol 934P [24] microspheres owing to its high 
viscosity in comparison to PVP and HPMC K15, the beads develops 
tail while in passing through the needle into the curing medium, so 
beads not forms spherical shape and gives an ovate/cylindrical 
shape like.  
So to avoid abnormal shape of beads, the position of needle have to 
keep in divert position like, this modification has to make only in 
formulation contains sodium alginate in combination with carbopol 
934P only. As the size of needle increases, the diameter of the needle 
decreases. The alginate beads prepared with different sizes of 
needles were observed. 
Morphology and size distribution 
Morphology of the various formulations of sodium alginate 
microspheres prepared was found to be in discrete and spherical 
appearance. The SEM photomicrographs of the dried alginate 
microspheres are shown in fig. 5. The surface of the alginate 
microspheres was rough due to a higher concentration of sodium 
alginate and uniformly dispersed of drug molecular level in the 
alginate matrices.  
Effect of sodium alginate on drug entrapment efficiency 
The higher viscosity of sodium alginate with different hydrophilic 
polymers at selected concentration will leads to decrease the rate of 
diffusion of drug into curing medium which would result in higher 
drug entrapment efficiency, this may be reason to greater 
availability of no. of active binding sites along polymeric chains and 
ultimately the degree of cross linking sites as the amount of alginate 
increased. 
Incorporation efficiency of microspheres 
The incorporation efficiency increased progressively with increasing 
sodium alginate concentration. An increase in the alginate 
concentration resulted in the formation of larger microspheres 
entrapping greater amounts of the drug. This may be attributed to 
the greater availability of active calcium-binding sites in the 
polymeric chains and, consequently, the greater degree of cross-
linking as the quantity of sodium alginate increased. 
+3  as compared to the beads cross-
linked with Ca +2. This may be attributed to the formation of 
nonporous alginate beads due to an increase in the apparent 
cross-linking density in presence of cations i.e. Al +3  which 
prevent the diffusion of the drug out of the beads at the time of 
curing.
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Fig. 5: SEM picture of mucoadhesive microbeads 
 












A1 20 11.78 58.90±0.53 47.67±1.78 1095 
B1 20 12.20 61.21±1.34 48.34±2.23 1074 
C1 20 11.01 55.05±0.41 48.79±0.59 1016 
D1 20 10.78 53.90±0.32 51.23±0.36 988 
E1 20 11.56 57.80±2.12 69.24±0.34 985 
*n = 3 (average±SD). 
 
The low incorporation efficiency of alginate beads cross-linked with 
Cacl+2
Polymer swelling and cross-linking are intimately connected to 
the release kinetics of the drugs from the swollen matrix. In 
order to investigate this effect, swelling results were obtained. 
Swelling of the beads was measured in terms of their percentage 
of water uptake at a selected time intervals. Swelling of cross 
linking alginate beads was observed little in acidic medium, In 
contrast to this, the rate of swelling will be more than triple 
times in presence of alkaline medium as it undergoes relaxation 
of the polymer. 
 could be attributed to the formation of porous beads ensuring 
the diffusion of the drug out of the beads at the time of curing. 
Swelling index 
 
Table 6: Percentage of swelling index with 3 % w/v sodium alginate with different hydrophilic polymers (0.3 % w/v), Each reading taken 
in triplicate 
 Time (h) Alg-carbopol 934p Alg-HPMC K15 Alg-PVP* 
2 (Acidic medium) 0.75±0.23 1.5±0.12 3.375±0.23 





Fig. 6: Erosion studies of different formulations, *Results are given in mean of triplicate 
 
Wash off test 
It gives knowledge regarding the ability of the polymer to adhere to 
the GI tract mucosa when it is thoroughly and continuously washed 
by 6.8 phosphate buffer/GI fluid. Microspheres with a coat 
consisting of sodium alginate and a mucoadhesive polymer 
exhibited good mucoadhesive properties as indicated by the in vitro 
wash-off test. Higher the adhesion to mucosa as well as greater 
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localisation of beads forms at the site of absorption if beads have a 
higher value of mucoadhesion rate.  
Beads prepared with carbopol 934P has higher mucoadhesion 
value, the reason due to the free carboxyl group which has high 
ability to form Covalent bonding with the mucin sites which 
present in mucous membrane whereas HPMC K15 polymer 
contains hydroxyl (-OH) groups. A hydroxy group present in HPMC 
K15 is less polar in comparison to the free carboxyl group of 
carbopol 934P. Hence a carbopol bead shows higher 
mucoadhesion as compared to HPMC. 
The study details reveals in vitro wash off was faster at simulated 
intestinal fluid (pH 6.8) than that simulated GI fluid (pH 1.2). pH of 
in vitro wash off medium has pronounced effect on solubility, 
hydration and mucoadhesivenss of the polymer. The polymers 
exhibiting relaxation property depends upon pH. 
The solubility of beads was faster at 6.8 buffer medium may be due 
to ionization of carboxy acid group i.e. sod. Alginate and other 
polymers. The decreased mucoadhesion of beads in phosphate 
buffer may result from erosion of aluminium ions which form a 
cross-linked structure. 
At higher solubility beads shows less mucoadhesive strength. The results 
of in vitro wash off test indicated that atorvastatin beads had fairly good 
mucoadhesive properties. The prepared beads would adhere to walls of 
mucus, thus restricting gastric emptying and prolong the residence tome 
of atorvastatin beads at absorption site, thereby it is possible to improve 
and increase the rate of bioavailability. 
 
Table 7: Result of in vitro wash-off test of micro beads in 0.1 N Hcl 
Time (h) Alg. with carbopol 934P Alg with HPMC Alg with PVP* 
1 88.67+1.32 75.76±5.67 79.78±4.12 
2 80.45±3.45 69.89±3.56 70.13±0.12 
4 60.78±3.67 50.45±5.98 51.21±8.34 
6 42.32±4.23 39.21±3.32 40.12±4.83 
8 34.78±8.65 23.32±4.43 30.23±2.78 
 *n = 3 (average±SD) 
 
Table 8: Result of in vitro wash-off test of microcapsules in 6.8 phosphate buffer 
Time (h) Alg. with carbopol 934P Alg with HPMC Alg with PVP 
1 75.12±1.23 60.34±1.56 70.23±5.45 
2 50.23±2.45 41.23±3.45 47.56±2.45 
4 29.56±0.23 20.12±4.56 25.67±6.03 
6 15.23±8.95 9.456±9.43 12.56±4.12 
8 5.78±3.76 0 3.45±3.32 
 Every reading taking in triplicate i.e. n = 3 (average±SD) 
 
X-ray diffraction studies 
The diffraction pattern of the pure drug showed characteristic high-
intensity diffraction peaks at 8.94, 9.34, 10.01, 10.38, 11.65, 12.20, 
16.84, 19.26, 21.36, 22.50, 23.11, and 23.51, which indicates that the 
drug is dispersed in the crystalline form that is also confirmed by DSC 
results. It is confirmed that the reflections of the pure drug match 
satisfactorily with the reflections of the drug in the microbeads 
formulation. Thus, it can be concluded that the polymorph of the pure 
drug was the same as that of atorvastatin polymorph incorporated in 
microbeads, and there are no transformation took place during the 
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Fig. 7: a) X-ray diffraction of pure atorvastatin and b) DSC 
spectra of pure atorvastatin calcium, c) DSC of pure carbopol 
934P d) X-ray diffraction of pure sodium alginate and (e) DSC 
spectra of physical mixture 
 
In vitro dissolution 
Alginate is insoluble in acidic pH i.e. 0.1N Hcl, and at low pH, the number 
of positively charged ions is high, and they minimise the electrical 
repulsion between the negatively charged alginate molecules. Alginate is 
protonated into the insoluble form of alginic acid molecules. Thus, 
penetration of dissolution fluid through the polymer matrix is hindered, 
and the percentage of drug released due to diffusion through the 
polymer network was minimal at pH 1.2 for all prepared beads.  
The rate of drug release from alginate-hydrophilic polymers i.e. 
carbopol 934P, HPMC K15 M and PVP. Beads formulated with a 
higher degree of cross-linking was more sustained than the beads 
formulated with a lower degree of cross-linking. Again, the release 
rate of atorvastatin in acid was found to be slower and more 
sustained. This may be due to the stability of alginate at acidic pH 
and the conversion of calcium/aluminium alginate to the insoluble 
but swelling alginic acid.  
The higher amount of drug release in 6.8 phosphate buffer than 
acidic buffer may be due to the higher swelling rate of the alginates 
in phosphate buffer medium. The presence of carbopol 934P and 
HPMC in the beads added to the network structure of the beads and 
in forced the degree of crosslinking due to its interaction with 
aluminium ions. This produces tight packing which disintegrates and 
dissociates slowly with subsequent slow release even in the 
intestinal phase. 
When pH is increased i.e. at 6.8 pH phosphate buffer, drug release is 
increased up to the maximum level. Deprotonation of alginic acid 
occurs at higher pH values. It will draw dissolution fluid into the 
beads, which causes swelling of beads and burst apart of the drug. 
  
 
Fig. 8: Dissolution profiles of pure atorvastatin, marketed brand and other formulations, *Results are given in mean of triplicate 
 
As the polymer concentration increased, diffusion resistance to drug 
release also increased, which, in turn, decreased in drug release [24-26].  
Positively charged groups of HPMC K15 strongly interact with 
alginate and atorvastatin ions, thus reducing both swelling and 
release probably due to protonation of carboxylated functional 
groups from Na-alginate molecules, and based on ficks law of 
diffusion, it may be inferred that as the viscosity of the formulation 
increases, molecular diffusivity (diffusion coefficient) and 
percentage release of drug also decreases 
The results indicated the more sustained effect with an increase in 
the viscosity of sodium alginate with different hydrophilic polymers. 
The first phase might be for the negligible dissociation of alginate 
beads in the acidic buffer and the drug release mainly based on drug 
diffusion through the formation of small pores and cracks upon 
swelling process. The second phase compared to initial phase 
exhibited a sustained release pattern, which was accompanied by 
rapid alginate disintegration of alginate in phosphate buffer than 
acidic medium. The sodium alginate combination with other 
hydrophilic polymers in the formulation greatly influenced the 
steady state release of atorvastatin from the alginate beads.  
Swelling of the polymer also leads to the formation of the matrix, 
thereby retarding the release of drug from the formulation [27, 28]. 
The higher mucoadhesion of carbopol 934P microspheres may also 
be attributed to the higher molecular weight of carbopol than HPMC 
[29]. These polymers are often used as a rate-controlling membrane 
to modulate the drug release from dosage forms with organic or 
aqueous coating techniques [30-33]. The principle of gelation or 
crosslinking of sodium alginate with aluminium chloride is based on 
the formation of a tight junction between the residues of guluronic 
acid. The number of the apparent cross-linking points within the 
formed aluminium alginate gel beads increased with increasing sod. 
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alginate concentration in the formulation. This increase in the 
intensity of crosslinking density delayed the alginate gel 
disintegration in 6.8 pH phosphate buffer due to the retardation of 
aluminium3+exchange with Na+. Increased alginate gel density per 
unit volume also affected the decreased pore size within the gels, 
and thus atorvastatin release becomes slow.  
The release behaviour of alginate microspheres, produced by 
ionotropic external gelation causes precipitation with different gelling 
agent’s ex. Cacl+2 and Alcl+3 depend upon the valency of ions and size 
of the cations of the respective cross-linking agent. To investigate this 
aspect, the sodium alginate (3.0% w/v) beads were prepared via cross 
linking in 5% w/v solution of cacl+2 and alcl+3
Drug release from the microspheres depends on the viscosities of 
the various polymers. Their release profile in 6.8 phosphate buffer 
was depicted in fig. 10. The sustained release pattern was observed 
in all formulations. The results obtained can be explained on the 
basis of the extent of cross-linking in the microspheres. Calcium 
chloride being a divalent forms two-dimensional network structure 
with sodium alginate inside the alginate matrices. In the case of Al
 respectively.  
+3 
alginate microspheres, the delay was due to the ability of Al+3 to 
form three-dimensional network structure with the sodium alginate 
inside the lattice of microspheres. This three-dimensional bonding 
results in an extended crosslinking through the whole microsphere, 
producing hard and compact alginate microspheres with less water 
uptake and thus leads to slow removal of Al+3 due to the exchange of 
ions with Na+ 
Kinetic modelling in vitro dissolution data was analyzed by 
different kinetic models in order to find out the n value, which 
describes the drug release mechanism. The values of coefficient of 
correlation (R
in the 6.8 phosphate buffer. As a result, the swelling of 
the beads are delayed leading to slow disintegration/ rupture of 
bead surface. 
2
The values of n for the release of atorvastatin from the alginate 
microspheres range between 1.376 and 2.927, indicating that the drug 
release from the microspheres followed the anomalous transport and 
super case-II transport mechanism controlled by swelling and 
relaxation of the polymer chains. Prepared micro beads were best 
fitted Higuchi model which indicated the drug release by diffusion in 
the slow and sustained way. 
) obtained for the respective model are listed in 
following table 9. Models with the highest correlation coefficient 
(R2) were judged to be the most appropriate model for the in vitro 
release study.  
 
Table 9: Release kinetics data of all formulations 
Batch code Zero order First order Higuchi matrix*  Korsmeyers Peppas* Hixon crowell equation* n value 

















































n = 3 (average±SD) 
CONCLUSION 
This study reveals that the sustained release of atorvastatin 
microbeads can be successfully achieved by ionotropic gelation 
technique using sodium alginate as a coating polymer and different 
hydrophilic polymers as release rate modifiers. To meet this 
objective, the microbeads were formulated by varying the 
processing conditions. The in vitro studies demonstrated that the 
microbeads formulated with 3 %w/v sodium alginate as coating 
polymer with 0.3% w/v of carbopol 934P under the presence of 100 
ml at 5% w/v aqueous aluminium chloride solution as curing 
reagent with 200 rpm offered sustained release rates for 10 h. The 
specifications of alginate beads depend on the composition of the 
beads. The addition of sodium alginate to viscosity modifiers i.e. as 
in form of carbopol 934P, pvp and hpmc k15 increases the drug 
entrapment efficiency and swelling property into these beads than 
alginate alone. As this method developed is highly simple, fast and 
reproducible. A delay in the release of atorvastatin was observed for 
the combination of sod. alginate and carbopol 934P beads. 
The value of n is 1.567 for the formulation which contains a 
combination of sodium alginate with carbopol 934P. The n value 
confirms that drug release from beads was followed super case-II 
transport mechanism indicates that drug control by swelling and 
relaxation of polymer chains. The optimized mucoadhesive 
microcapsules exhibited good flow properties, mucoadhesive 
potential, better drug entrapment efficiency, and the desired release 
characteristics. Matrix swelling induced by 6.8 phosphate buffer and 
drug release is proved to be a function of pH based. Thus, this study 
concludes that the performance of the microbeads can be altered by 
changing the processing variables involved in the production of 
stabled cross-linked atorvastatin microbeads. 
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